hsa-miR-125b

ncRNA information

ncRNA name

hsa-miR-125b

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

HAX-1

Cancer information

Cancer name

Breast Cancer

Cancer site

Breast

Treatment information

Treatment type

Chemotherapy

Drug

Doxorubicin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Up

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

It was demonstrated that the overexpression of miR-125b increased the sensitivity of MCF-7/R cells to DOX.

Tissue resource

pairs of breast cancer tumor and corresponding adjacent non-tumor tissues

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

Dongyang People's Hospital

Country

China

Continent

Asia